Israeli Hospitals Destroy Tumors With Liquid Nitrogen
IceCure Medical, an Israeli company developing a minimally invasive medical device for treating tumors, recently announced that it will start offering its technology, called cryoablation, in Israel in upcoming weeks.
The company’s device is an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor and does not require hospitalization, leaves minimal to no scarring, and has a short recovery time. Destroyed tumor cells are then reabsorbed in the body over time.
The treatment, which is approved in the US and the European Union, will be available in Israel to women suffering from fibroadenomas, benign breast tumors usually found in women under 30, and for patients with malignant kidney tumors.
Article excerpts from calcalisttech.com
Related Articles
A Snowy New York Night Benefits the Great Rabin Medical Center of Israel
In the midst of the snowstorm on Thursday, February 25th, over two-hundred young professionals assembled in SoHo, NYC for The American Friends of Rabin Medical Center's 5th annual New Circle real estate charity event.
iPad Catheterization Application Used for the First Time at Rabin Medical Center
A new advanced technology has been developed for the first time worldwide, at Rabin Medical Center's Invasive Cardiology Institute, where all pertinent information collected during the cardiac catheterization procedure is sent directly to an iPad.
Fourteenth Annual Gala Review: Thank You!!!
We hosted our Fourteenth Annual Gala at Cipriani 42nd Street, NYC honoring Norman Sturner CEO & President of Murray Hill Properties with a sold out crowd of 620 guests.